Buscar resultados de ensayos clínicos

Patrocinado por

Limb-girdle Muscular Dystrophy - 19 Studies Found

Estado Estudiar
Enrolling by invitation Nombre del estudio: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies
Condición:
  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Fecha: 2010-05-18
    Intervenciones: Drug: Coenzyme Q10 and Lisinopril Arm 1. Coenzyme Q10: taken once a day each morning by mouth OR Arm 2.
Completed Nombre del estudio: Cardiac Magnetic Resonance in Children With Muscular Dystrophy
Condición:
  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Fecha: 2010-03-04
Completed Nombre del estudio: Cardiac Outcome Measures in Children With Muscular Dystrophy
Condición:
  • Duchenne Muscular Dystrophy
  • Becker Muscular Dystrophy
  • Fecha: 2010-02-09
Completed Nombre del estudio: Study Evaluating MYO-029 in Adult Muscular Dystrophy
Condición:
  • Becker Muscular Dystrophy
  • Facioscapulohumeral Muscular Dystrophy
  • Limb-girdle Muscular Dystrophy
  • Duchenne Muscular Dystrophy

    • Fecha: 2006-10-17
Completed Nombre del estudio: Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy
Condición:
  • Muscular Dystrophies
  • Duchenne Muscular Dystrophy
  • Becker Mu
    Fecha: 2009-04-01
    Intervenciones: Other: Retrograde high pressure transvenous perfusion with normal saline Dose escalation of saline volum
Completed Nombre del estudio: Acceptance and Commitment Therapy for Muscle Disease
Condición: Muscle Diseases
Fecha: 2016-06-20
Intervenciones: Behavioral: Acceptance and Commitment Therapy (ACT) Acceptance and Commitment Therapy (ACT) is a form of
Recruiting Nombre del estudio: A Trial of PF-06252616 in Ambulatory Participants With LGMD2I
Condición: LGMD2I
Fecha: 2016-07-12
Intervenciones: Drug: PF 06252616
Completed Nombre del estudio: Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)
Condición: Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)
Fecha: 2025-09-03
Intervenciones: The BBP-418 drug product is provided as Granules for Oral solution consisting of BBP-418 drug substance and silicon dioxide in a multilaminate sachet
<<< Previous